¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ International AD Summit Seoul(IASS) 2022(1ÀÏÂ÷) : 2022-06-04

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ International AD Summit Seoul(IASS) 2022(1ÀÏÂ÷) : 2022-06-04
±³À°ÀÏÀÚ : 2022-06-04
±³À°Àå¼Ò : ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ±×·£µåº¼·ý ¹éµÎ  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ) International AD Summit Seoul(IASS) 2022(1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ  
´ã´çÀÚ : ÃÖ°æ¼ö
¿¬¶ôó : 02-2038-7674  
À̸ÞÀÏ : IASS2022@humming.co.kr      
±³À°Á¾·ù : ÇǺΰú      
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 500,000¿ø      
ºñ°í 1. Çѱ¹ÀÎ : ÇöÀåµî·Ï (ÇǺΰú Àü¹®ÀÇ 5¸¸, ÇǺΰúÀü°øÀÇ 2¸¸) ¿Â¶óÀÎ(ÇǺΰúÀü¹®ÀÇ 2¸¸, ÇǺΰúÀü°øÀÇ ¹«·á) ´Ü, ÇǺΰúÀü°øÀ̾ƴѰæ¿ì : ÇöÀå¹×¿Â¶óÀÎ ¸ðµÎ 50¸¸ 2. ¿Ü±¹ÀÎ: ÇǺΰúÀü°ø°ü·ÃÀÚ ÇöÀå ¹× ¿Â¶óÀÎ ¸ðµÎ ¹«·á. ´Ü, ÇǺΰú °ü·Ã Àü°øÀÚ°¡ ¾Æ´Ñ°æ¿ì 400$      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-02 ¹éµÎ 09:30~10:00 Mechanistic insights into IL-13 in atopic dermatitis pathophysiology  Dong-Hun Lee (À̵¿ÈÆ)(Seoul National University Hospital (¼­¿ï´ëÇб³º´¿ø)) 
±³À°½Ã°£ 06-02 ¹éµÎ 10:00~10:30 Immunopathologic considerations and characteristics in atopic dermatitis compared with psoriasis  Tae-Young Han (ÇÑÅ¿µ)(Nowon Eulji Medical Center (³ë¿øÀ»Áö´ëÇб³º´¿ø)) 
±³À°½Ã°£ 06-02 ¹éµÎ 10:30~11:00 How about the others such as TH17 & 22 in atopic dermatitis pathogenesis?  Yong-Hyun Jang (Àå¿ëÇö)(Kyungpook National University Hospital (°æºÏ´ëÇб³º´¿ø)) 
È޽Ġ06-02 ¹éµÎ 11:00~11:20 Coffee break  () 
±³À°½Ã°£ 06-02 ¹éµÎ 11:20~12:00 Safety of JAK inhibitors: lessons rheumatology experiences  Seoyoung C Kim(Medicine Brigham and Women¡¯s Hospital and Harvard Medical SchoolUSA) 
±³À°½Ã°£ 06-02 ¹éµÎ 12:00~12:40 What should be the 1st option for moderate to severe atopic dermatitis patiiients? Deep dive in H2H data between JAKi vs biologics  Kilian Eyerich(University of Freiburg Karolinska Institutet Sweden) 
½Ä»ç 06-02 ¹éµÎ 12:40~13:20   () 
±³À°½Ã°£ 06-02 ¹éµÎ 13:20~14:10 Role of IL-17A producing innate lymphoid cells in the pathogenesis of atopic dermatitis  Kyu-Han Kim (±è±ÔÇÑ)(Seoul National University Hospital (¼­¿ï´ëÇб³º´¿ø)) 
±³À°½Ã°£ 06-02 ¹éµÎ 14:10~14:40 Clinical characteristics and a new treatment challenge in children atopic dermatitis  Sang-Eun Lee (ÀÌ»óÀº)(Gangnam Severance Hospital (°­³²¼¼ºê¶õ½ºº´¿ø)) 
±³À°½Ã°£ 06-02 ¹éµÎ 14:40~15:10 The needs for definition and diagnostic criteria of elderly atopic dermatitis  Min-Kyung Shin (½Å¹Î°æ)(Kyung Hee University Medical Center (°æÈñ´ëÇб³º´¿ø)) 
È޽Ġ06-02 ¹éµÎ 15:10~15:30 Coffee break  () 
±³À°½Ã°£ 06-02 ¹éµÎ 15:30~16:10 Treat-to-target in atopic dermatitis : what¡¯s different with psoriasis?  Peter Foley(University of Melbourne Australia) 
±³À°½Ã°£ 06-02 ¹éµÎ 16:10~16:35 Evolving practice guidelines in atopic dermatitis  Hyun-Chang Ko (°íÇöâ)(Pusan National University Hospital Yangsan hospital (¾ç»êºÎ»ê´ëÇб³º´¿ø)) 
±³À°½Ã°£ 06-02 ¹éµÎ 16:35~17:10 Burden and Pathophysiology of Atopic Dermatitis and the role of the JAK/STAT pathway in AD(TBD)  Michael Ardern-Jones(University of Southampton UK) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ International AD Summit Seoul(IASS) 2022(1ÀÏÂ÷) : 2022-06-04""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѾÆÅäÇÇÇǺο°ÇÐȸ International AD Summit Seoul(IASS) 2022(2ÀÏÂ÷) : 2022-06-05
´ÙÀ½±Û (¿Â¶óÀÎ)´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ Á¦6ȸ ¹Ì·¡Æ÷·³ : 2022-06-04
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20805 ¼­¿ï 2024 ´ëÇÑ»ê°ú¸¶ÃëÇÐȸ Á¦27Â÷ Çмú´ëȸ : 2024-06-15 0 8 2024-05-27
20804 ÃæºÏ 204 ÃæûºÏµµÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-06-15 0 9 2024-05-27
20803 ºÎ»ê 2024³â Á¦7ȸ ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ Áý´ãȸ : 2024-06-15 0 6 2024-05-27
20802 ºÎ»ê 2024³â ´ëÇÑÁßȯÀÚÀçÈ°ÇÐȸ ¿öÅ©¼¥-±â´ÉÀû Æò°¡ ¹× ÁßȯÀÚ ÀçÈ°ÀÇ ½ÇÁ¦ (¿Ü»ó ÁßȯÀÚ Æ÷ÇÔ) : 2024-06-15 0 8 2024-05-27
20801 ¼­¿ï KLASS 20Áֳ⠱â³ä 2024 ´ëÇѺ¹°­°æÀ§Àå°ü¿¬±¸È¸ Á¦27ȸ Á¤±âÇмú´ëȸ : 2024-06-15 0 8 2024-05-27
20800 °æ±â 2024³â Á¦ 3ȸ Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-15 0 14 2024-05-27
20799 ¼­¿ï (¿Â¶óÀÎ) 2024³âµµ ÀÓ»óÁø·áÁöħ Æò°¡À§¿ø ¾ç¼º±³À° : 2024-06-15 0 9 2024-05-27
20798 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾÆû¼Ò³â°ú ºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-15 0 3 2024-05-27
20797 ¼­¿ï ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ COPD School 2024 : 2024-06-15 0 7 2024-05-27
20796 ¼­¿ï »óóÀå·ç¿¬±¸È¸ Áý´ãȸ : 2024-06-15 0 5 2024-05-27
20795 Àü³² 2024³â Àü¶ó³²µµÀÇ»çȸ Àü¹Ý±â Çмú´ëȸ : 2024-06-15 0 9 2024-05-27
20794 ¼­¿ï Ç÷°ü¿µ»ó»ý¸®¿¬±¸È¸ IPOP(Imaging and Physiology on Patients with Cardiovascular Disease) 2024 : 2024-06-15 0 5 2024-05-27
20793 ¼­¿ï ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ¾à¹°¾Ë·¹¸£±â ½ÉÆ÷Áö¾ö : 2024-06-15 0 10 2024-05-27
20792 ´ëÀü ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ ´ëÀü, ÃæûÁöȸ - Á¦3Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-15 0 4 2024-05-27
20791 ¼­¿ï Á¦51ȸ ´ëÇÑÀÓ»óÇǺÎÄ¡·á¿¬±¸È¸ ±³À°½ÉÆ÷Áö¾ö : 2024-06-15 0 8 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷